Seegnal
Eyal Schneid has a diverse work experience spanning over two decades, including executive leadership roles in various global technology companies. Eyal is currently associated with Seegnal as CEO, and their previous roles include Chief Commercial Officer at Seegnal, VP at Sapiens, SVP at CSG International, Vice President at TechSee, Regional Vice President at Netcracker Technology, and Director at Amdocs. Eyal has also held executive positions at WizcomTech, The Q Group, and 013 Netvision, where they were responsible for sales and marketing functions, devising go-to-market strategies, and managing P&L in multiple business units. Throughout their career, Eyal has focused on revitalizing businesses, turning around complex transformation programs, increasing sales, diversifying products and services, and handling delivery and operational challenges.
Eyal Schneid has a Bachelor of Arts degree with honors in Marketing & Information Systems from The Academic College of Tel-Aviv, Yaffo. Eyal also has a Master of Business Administration degree in Marketing from The University of Manchester. The exact dates of their education are unknown.
This person is not in any teams
This person is not in any offices
Seegnal
Seegnal is dedicated to the creation, marketing, and service of proprietary technology solutions for the eHealth industry. Seegnal was founded in 2015 by Roni Shiloh, MD, a practicing psychiatrist who identified the unmet need for an effective clinical decision support system to address and resolve Drug Related Problems (DRP) at the point of care, while treating patients. Seegnal is an ‘all-in-one’, patient-adaptive CDSS platform that enables healthcare professionals to address, in seconds, only the DRPs that are relevant to the specific patient and select appropriate treatment alternatives. Seegnal’s identified outputs are backed by globally-acknowledged expertise while providing a one-glance, innovative GUI operation (±1% of the time compared to other systems) and exceptional, over 90%, sensitivity & specificity.